LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,013,000 | -10.0% | 43,919 | -0.8% | 0.31% | -10.9% |
| Q1 2019 | $5,568,000 | +1.1% | 44,289 | +9.1% | 0.35% | +3.0% |
| Q4 2018 | $5,508,000 | -1.6% | 40,590 | +99.0% | 0.34% | +29.0% |
| Q3 2018 | $5,599,000 | -23.2% | 20,397 | -42.0% | 0.26% | -23.6% |
| Q2 2018 | $7,290,000 | +39.5% | 35,188 | +11.2% | 0.34% | +33.5% |
| Q1 2018 | $5,227,000 | +6.3% | 31,650 | -11.9% | 0.26% | +18.4% |
| Q4 2017 | $4,918,000 | -20.0% | 35,916 | -20.4% | 0.22% | -13.9% |
| Q3 2017 | $6,145,000 | -24.5% | 45,134 | -32.7% | 0.25% | -26.7% |
| Q2 2017 | $8,137,000 | +50.6% | 67,026 | +31.3% | 0.34% | +53.6% |
| Q1 2017 | $5,404,000 | -34.3% | 51,059 | -37.4% | 0.22% | -38.3% |
| Q2 2015 | $8,228,000 | +5.5% | 81,547 | -19.4% | 0.36% | +7.4% |
| Q1 2015 | $7,802,000 | – | 101,186 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |